carubicin and Lymphoma--Large-B-Cell--Diffuse

carubicin has been researched along with Lymphoma--Large-B-Cell--Diffuse* in 1 studies

Trials

1 trial(s) available for carubicin and Lymphoma--Large-B-Cell--Diffuse

ArticleYear
[Study of the antitumor activity of carminomycin in malignant tumors in children (a preliminary report)].
    Antibiotiki, 1976, Volume: 21, Issue:7

    Side reactions and therapeutic effect of carminomycin were studied in 21 children with various malignant tumors. Carminomycin was administered intravenously in doses of 0.15-0.2 mg/kg twice a week for 2-3 weeks. The treatment courses were repeated in a month. The drug was better tolerated by children than by adults. After the treatment course leucopenia may develop. When used alone or in combination with vincristin or cyclophosphan carminomycin proved to be effective in treatment of sarcoma of the soft tissues (liposarcoma, synovial sarcoma), chondrosarcoma and reticulosarcoma.

    Topics: Adolescent; Antibiotics, Antineoplastic; Carubicin; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Moscow; Neoplasms; Remission, Spontaneous; Sarcoma

1976